Interview with
CoTherix, Inc. (CTRX - NASDAQ)
Crystal Research Associates provides independent equity research coverage of CoTherix, Inc. (CTRX - NASDAQ), including a company snapshot, executive informational overview (EIO), and quarterly updates.
Cotherix is a biopharmaceutical company focused on the treatment of cardiovascular disease.
Please visit the Research Coverage link below for greater details on CoTherix, including the base reports and quarterly updates.